Females with angina pectoris have altered lipoprotein metabolism with elevated cholesteryl ester transfer protein activity and impaired high-density lipoproteins-associated antioxidant enzymes

W RosamondK FlegalK FurieA GoK GreenlundN HaaseSM HailpernM HoV HowardB KisselaS KittnerD Lloyd-JonesM McDermottJ MeigsC MoyG NicholC O’DonnellV RogerP SorlieJ SteinbergerT ThomM WilsonY HongAmerican Heart Association Statistics Committee and Stroke Statistics SubcommitteeHeart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics SubcommitteeCirculation117e25e146200810.1161/CIRCULATIONAHA.107.18799818086926

C CannonE BraunwaldUnstable angina and non-ST elevation myocardial infarction In: Harrison’s Principles of Internal MedicineDL KasperE BraunwaldAS FauciSL HauserDL LongoJL Jameson16th editionMcGraw-HillNew York144414482005

E JawadR AroraChronic stable angina pectorisDis Mon54671689200810.1016/j.disamonth.2008.06.009

V BittnerBD JohnsonI ZinehWJ RogersD VidoOC MarroquinCN Bairey-MerzG SopkoThe triglyceride/high-density lipoprotein cholesterol ratio predicts all-cause mortality in women with suspected myocardial ischemia: a report from the Women’s Ischemia Syndrome Evaluation (WISE)Am Heart J157548555200919249427

K ThygesenJS AlpertHD WhiteJoint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionAS JaffeFS AppleM GalvaniHA KatusLK NewbyJ RavkildeB ChaitmanPM ClemmensenM DellborgH HodP PorelaR UnderwoodJJ BaxGA BellerR BonowEE Van der WallJP BassandW WijnsTB FergusonPG StegBF UretskyDO WilliamsPW ArmstrongEM AntmanKA FoxCW HammEM OhmanML SimoonsPA Poole-WilsonEP GurfinkelJL Lopez-SendonP PaisS MendisJR ZhuLC WallentinF Fernández-AvilésKM FoxAN ParkhomenkoSG PrioriM TenderaLM Voipio-PulkkiA VahanianAJ CammR De CaterinaV DeanK DicksteinG FilippatosC Funck-BrentanoI HellemansSD KristensenK McGregorU SechtemS SilberM TenderaP WidimskyJL ZamoranoJ MoraisS BrenerR HarringtonD MorrowM LimMA Martinez-RiosS SteinhublGN LevineWB GiblerD GoffM TubaroD DudekN Al-AttarUniversal definition of myocardial infarctionCirculation11626342653200710.1161/CIRCULATIONAHA.107.18739717951284

G WalldiusI JungnerIs there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I-new risk factors and targets for therapyNutr Metab Cardiovasc Dis17565571200710.1016/j.numecd.2007.02.01017631989

S TsimikasJT WillersonPM RidkerC-Reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patientsJ Am Coll Cardiol47C19C31200610.1016/j.jacc.2005.10.06616631506

XS HuangSP ZhaoQ ZhangL BaiM HuElevated plasma apolipoprotein AV in acute coronary syndrome is positively correlated with triglyceride and C-reactive proteinChin Med J (Engl)12214081412200919567162

J TashiroO MiyazakiY NakamuraA MiyazakiI FukamachiH BujoY SaitoPlasma pre beta1-HDL level is elevated in unstable angina pectorisAtherosclerosis204595600200910.1016/j.atherosclerosis.2008.10.01519054517

KH ChoDG ShinSH BaekJR KimMyocardial infarction patients showed altered lipoprotein properties and functions when compared with stable angina pectoris patientsExp Mol Med416776200910.3858/emm.2009.41.2.009

SJ LeeH CamposLA MoyeFM SacksLDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patientsArterioscler Thromb Vasc Biol23853858200310.1161/01.ATV.0000066131.01313.EB12637336

M HartfordO WiklundL Mattsson HulténA PerssonT KarlssonJ HerlitzK CaidahlC-reactive protein, interleukin-6, secretory phospholipase A group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromesJ Intern Med262526536200710.1111/j.1365-2796.2007.01862.x

KH ParkDG ShinJR KimKH ChoThe functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activityInt J Mol Med251291362010

T McLaughlinF AbbasiK ChealJ ChuC LamendolaG ReavenUse of metabolic markers to identify overweight individuals who are insulin resistantAnn Intern Med139802809200310.7326/0003-4819-139-10-200311180-0000714623617

JJ Genest JrSS Martin-MunleyJR McNamaraJM OrdovasJ JennerRH MyersSR SilbermanPW WilsonDN SalemEJ SchaeferFamilial lipoprotein disorders in patients with premature coronary artery diseaseCirculation8520252033199210.1161/01.CIR.85.6.20251534286

RJ HavelHA EderJH BragdonThe distribution and chemical composition of ultracentrifugally separated lipoproteins in human serumJ Clin Invest3413451353195510.1172/JCI10318213252080

MA MarkwellSM HaasLL BieberNE TolbertA modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samplesAnal Biochem87206210197810.1016/0003-2697(78)90586-998070

MS BloisAntioxidant determinations by the use of a stable free radicalNature18111991200195810.1038/1811199a0

IF BenzieJJ StrainThe ferric reducing ability of plasma (FRAP) as a measure of antioxidant power: the FRAP assayAnal Biochem2397076199610.1006/abio.1996.02928660627

KH ChoSynthesis of reconstituted high-density lipoprotein (rHDL) containing apoA-I and apoC-III: the functional role of apoC-III in rHDLMol Cells27291297200910.1007/s10059-009-0037-819326075

JM HanTS JeongWS LeeI ChoiKH ChoStructural and functional properties of V156K and A158E mutants of apolipoprotein A-I in the lipid-free and lipid-bound statesJ Lipid Res46589596200510.1194/jlr.M400468-JLR20015716588

KH ChoJY LeeMS ChoiJM ChoJS LimYB ParkA peptide from hog plasma that inhibits human cholesteryl ester transfer proteinBiochim Biophys Acta1391133144199810.1016/S0005-2760(97)00197-59554982

HW EckersonCM WyteBN La DuThe human serum paraoxonase/arylesterase polymorphismAm J Hum Genet351126113819836316781

HF BoydSC FellST FlynnDM HickeyRJ IfeCA LeachCH MacpheeKJ MillinerKE MooresIL PintoRA PorterDA RawlingsSA SmithIG StansfieldDG TewCJ TheobaldCM WhittakerN-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2Bioorg Med Chem Lett1025572561200010.1016/S0960-894X(00)00510-211086729

KH ChoSH ParkJE ParkYO KimI ChoiJJ KimJR KimThe function, composition, and particle size of high-density lipoprotein were severely impaired in an oliguric phase of hemorrhagic fever with renal syndromeClin Biochem415664200810.1016/j.clinbiochem.2007.10.00717996200

A JahangiriMC de BeerV NoffsingerLR TannockC RamaiahNR WebbDR van der WesthuyzenFC de BeerHDL remodeling during the acute phase responseArterioscler Thromb Vasc Biol29261267200910.1161/ATVBAHA.108.17868119008529

PE McBrideTriglycerides and risk for coronary heart diseaseJ Am Med Assoc298336338200710.1001/jama.298.3.33617635897

P LibbyFat fuels the flame triglyceride-rich lipoproteins and arterial inflammationCirculation100299301200710.1161/01.RES.0000259393.89870.5817307968

R OstfeldD MookherjeeM SpinelliD HoltzmanA ShoyebM SchaeferS DoddamaniD SpevackY DuA triglyceride/high-density lipoprotein ratio > or = 3.5 is associated with an increased burden of coronary artery disease on cardiac catheterizationJ Cardiometab Syndr113152006

KH ParkDG ShinJR KimKH ChoSenescence-related truncation and multimerization of apolipoprotein A-I in high-density lipoprotein with an elevated level of advanced glycated end products and cholesteryl ester transfer activityJ Gerontol A Biol Sci Med Sci65600610201010.1093/gerona/glq034

MJ ChapmanWL GoffM GuerinA KontushCholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitorsEur Heart J31149164201010.1093/eurheartj/ehp399

MJ ChapmanTherapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart diseasePharmacol Ther111893908200610.1016/j.pharmthera.2006.02.00316574234

M ZellerD MassonM FarnierL LorgisV DeckertJP Pais de BarrosC DesrumauxP SicardJ GroberD BlacheP GambertL RochetteY CottinL LagrostHigh serum cholesteryl ester transfer rates and small high-density lipoproteins are associated with young age in patients with acute myocardial infarctionJ Am Coll Cardiol5019481955200710.1016/j.jacc.2007.06.05217996559

BJ ArsenaultI LemieuxJP DesprésP GagnonNJ WarehamES StroesJJ KasteleinKT KhawSM BoekholdtHDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population studyAtherosclerosis206276281200910.1016/j.atherosclerosis.2009.01.044

M GurM AslanA YildizR DemirbagR YilmazS SelekO ErelI OzdogruParaoxonase and arylesterase activities in coronary artery diseaseEur J Clin Invest36779787200610.1111/j.1365-2362.2006.01727.x17032345

K KarasawaClinical aspects of plasma platelet-activating factor-acetylhydrolaseBiochim Biophys Acta176113591372200610.1016/j.bbalip.2006.06.01717049457

DA SixEA DennisThe expanding superfamily of phospholipase A(2) enzymes: classification and characterizationBiochim Biophys Acta1488119200010.1016/S1388-1981(00)00105-011080672